Merck in the news
ShareCopied to clipboardAnalyze the latest Merck news, with a current neutral sentiment polarity (-0.05) or the entire set.
Latest news
Here are the latest news on this scope:
Merck lowers profit outlook, partly due to $200 million expected tariff hit
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Stocks making the biggest moves premarket: Pfizer, PepsiCo, Palantir, Merck and more
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck
China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion
Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion
Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda
Extract data
Extract all the news on this scope:
Visualize data
Here are some available charts on these news:
Evolution through time
Distribution of sources in the news
Distribution of sections in the news
Sentiment polarity through time